Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
BMJ Case Reports
|
December 22, 2012
Acute functional deterioration in a child with cerebral palsy
Elizabeth Smyth, Chandrasekaran Kaliaperumal, Jane Leonard, et al.
Plos One
|
July 31, 2019
The short-term effects of selective dorsal rhizotomy on gait compared to matched cerebral palsy control groups
Rory O'Sullivan, Jane Leonard, Aoife Quinn, et al.
The Australasian Journal of Dermatology
|
August 11, 2010
PlayStation purpura
Susan J Robertson, Jane Leonard, Alex J Chamberlain
The Pediatric Infectious Disease Journal
|
April 14, 2018
Expanding the Spectrum of Post-malaria Neurologic Syndrome in the Pediatric Population
Robert J Kernan, Patrick J Gavin, Karina M Butler, et al.
Archives of Disease in Childhood
|
July 2, 2015
Severe combined immunodeficiency syndrome presenting with disseminated BCG infection
Patrick Fitzpatrick, Jane Leonard, Eilis Twomey, et al.
Cancer
|
May 19, 2016
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors
Julie N Graff, Celestia S Higano, Noah M Hahn, et al.
Leukemia Research Reports
|
July 29, 2014
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Stuart L Goldberg, Pierre Fenaux, Michael D Craig, et al.
Journal of Pain Research
|
August 5, 2024
Identification of Presurgical Risk Factors for the Development of Chronic Postsurgical Pain in Adults: A Comprehensive Umbrella Review
Beate C Sydora, Lindsay Jane Whelan, Benjamin Abelseth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas
Jonathan W Friedberg, Daruka Mahadevan, Erin Cebula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2022
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
BMJ Case Reports
|
December 22, 2012
Acute functional deterioration in a child with cerebral palsy
Elizabeth Smyth, Chandrasekaran Kaliaperumal, Jane Leonard, et al.
Plos One
|
July 31, 2019
The short-term effects of selective dorsal rhizotomy on gait compared to matched cerebral palsy control groups
Rory O'Sullivan, Jane Leonard, Aoife Quinn, et al.
The Australasian Journal of Dermatology
|
August 11, 2010
PlayStation purpura
Susan J Robertson, Jane Leonard, Alex J Chamberlain
The Pediatric Infectious Disease Journal
|
April 14, 2018
Expanding the Spectrum of Post-malaria Neurologic Syndrome in the Pediatric Population
Robert J Kernan, Patrick J Gavin, Karina M Butler, et al.
Archives of Disease in Childhood
|
July 2, 2015
Severe combined immunodeficiency syndrome presenting with disseminated BCG infection
Patrick Fitzpatrick, Jane Leonard, Eilis Twomey, et al.
Cancer
|
May 19, 2016
Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors
Julie N Graff, Celestia S Higano, Noah M Hahn, et al.
Leukemia Research Reports
|
July 29, 2014
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Stuart L Goldberg, Pierre Fenaux, Michael D Craig, et al.
Journal of Pain Research
|
August 5, 2024
Identification of Presurgical Risk Factors for the Development of Chronic Postsurgical Pain in Adults: A Comprehensive Umbrella Review
Beate C Sydora, Lindsay Jane Whelan, Benjamin Abelseth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2013
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas
Jonathan W Friedberg, Daruka Mahadevan, Erin Cebula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2022
Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor
José Á García-Sáenz, Noelia Martínez-Jáñez, Ricardo Cubedo, et al.
Page
of 2